Publications
Archives
BCIQ
Conferences
Free Trial
/
Subscribe
Sign In
English
简体中文
日本語
한국어
more_vert
Biocentury
// BCIQ
Menu
Home
Publications
Publications Home
BioCentury
BC Innovations
BC Extra
BC Week In Review
Current Issues
Archives
Archives Home
Basic Search
Advanced Search
Back Issues
BCIQ
BCIQ Home
Overview
Newsfeed
Companies
Products
Finance
Deals
Conferences
Conferences Home
Newsmakers
Bio€quity Europe
Future Leaders
China Healthcare Summit
Other Industry Events
eLearning
eLearning Home
Videos
White Papers
Follow Us
Newsfeed
Companies
Products
Finance
Deals
Profile Reports
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
1 documents
BC Week In Review
1
Clinical News
1
Regulatory
1
Read All
08:00
,
Dec 21, 2015
|
BC Week In Review
|
Clinical News
S48168 regulatory update
FDA granted rare pediatric disease and Orphan Drug designation to ARM210 from Armgo to treat Duchenne muscular dystrophy (DMD). ARM210 is in Phase I testing for DMD. The product is an oral Rycal, a small...
Read More